7 registrations that name krill oil as a study arm and are recruiting or about to, as ClinicalTrials.gov listed them on Oct 20, 2026. Read each listing for its full criteria and current status.
Kymata never assesses eligibility. Each listing names its own criteria; only its study team can say whether someone can join. Trial doses are given under the trial's monitoring and are not a schedule for anyone outside it.
Filter 7 registrations
Status
Phase
All 7 registrations
RecruitingNCT06296875
The Krill Ageing Muscle Mechanisms (KAMM) Study
No phase
University of Glasgow
About 80 people
Started Sep 1, 2024
In plain words A study of krill oil in people 65 to 90, run by University of Glasgow. It plans to enroll about 80 people at 1 site, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 65 to 90; healthy volunteers accepted. Conditions: Sarcopenia.
body mass index (BMI) </= 30 kg/m2
Age >/= 65 years
Capacity to consent
Living within the Glasgow area
The exclusion criteria are on the listing.
What it tests, as registered
Vegetable oil; Krill oil
Registered summary
This study aims to determine the mechanisms via which krill oil supplementation increases muscle strength and whether this translates to improvements in gait and functional characteristics in older adults. The studies we will carry out will establish, in healthy older adults, the effects of 6 months of supplementation with krill oil Objective 1) Muscle structure and function Hypothesis: Krill oil supplementation will increase muscle size and strength alongside positive changes in muscle architecture (pennation angle and fascicle length). The full summary is on the listing.
Where, as registered
No US site; United Kingdom (1).
RecruitingNCT06939244
Investigating the Effects of Krill Oil on the Recovery From Muscle Damaging Exercise: a Randomised Controlled Trial
No phase
University of Glasgow
About 32 people
Started Feb 1, 2025
In plain words A study of krill oil in people 60 and older, run by University of Glasgow. It plans to enroll about 32 people at 1 site, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 60 and older; healthy volunteers accepted. Conditions: Looking at the Effects of Krill Oil Supplementation on Recovery From Muscle-damaging Exercise.
Be 60 years old or older
Have a BMI of less than 30kg/m2
Participating in resistance-type exercise for less than 1h per week
The exclusion criteria are on the listing.
What it tests, as registered
Krill oil
Registered summary
1\. What will happen to me if I take part? All study visits will be at the University of Glasgow main campus within the Sir James Black building. Initial visit (duration 1 hours) We will ask that for each study visit you come to the laboratory with clothing suitable to exercise in (loose shorts) for your own comfort and to also make it easier for us to complete certain measurements where access to upper legs will be necessary. Changing facilitates will be provided on-site. After the screening process, your physical activity and your diet will be assessed via questionnaires. The full summary is on the listing.
Where, as registered
No US site; United Kingdom (1).
RecruitingNCT07130513
Investigating the Feasibility of Krill Oil Intervention to Improve Muscle Function in Adults With Long-term Conditions
No phase
University of Glasgow
About 30 people
Started Aug 18, 2025
In plain words A study of krill oil in people 18 and older, run by University of Glasgow. It plans to enroll about 30 people at 2 sites, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 18 and older. Conditions: Krill Oil; Muscle Function; Grip Strength; Long-Term Conditions; Omega 3 Fatty Acids.
Men and women aged ≥18 years who are in the high-risk long-term condition group (having one or more LTCs, including rheumatoid arthritis, gout, type 2 diabetes, coronary heart disease, and stroke \[including transient ischemic attack,…
The exclusion criteria are on the listing.
What it tests, as registered
Krill oil supplementation; Control
Registered summary
This study will recruit 30 adults (men and women, aged 18 years and over) who will be randomly assigned to one of two groups in a 12-week double-blind pilot trial. Participants will receive either: * Arm 1: Krill Oil group: 4 g/day of krill oil supplements (Superba™ Antarctic Krill Oil, 1000 mg capsules), or * Arm 2: Control group: 4 g/day of placebo (vegetable oil capsules). Participants will be instructed to maintain their usual diet and physical activity patterns throughout the study. The full summary is on the listing.
Where, as registered
No US site; United Kingdom (2).
RecruitingNCT05465252
Effect of Omega-3 Fatty Acid Supplementation on Dry-AMD Progression
No phase
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
About 24 people
Started Oct 17, 2025
In plain words A study of krill oil in people 50 to 85, run by Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine. It plans to enroll about 24 people at 1 site, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 50 to 85. Conditions: Age-Related Macular Degeneration.
Adults diagnosed with dry AMD at an early or intermediate stage, classified according to the Beckman Classification and confirmed by fundus photography: (1) Early AMD: medium drusen (>63 μm and ≤125 μm) without AMD-related pigmentary…
Willing to stop supplementation of omega-3 fatty acids, choline, or astaxanthin.
Willing to sign the informed consent, and willing to attend follow-up visits for at least 3 months.
The exclusion criteria are on the listing.
What it tests, as registered
Krill Oil; Olive Oil
Registered summary
This randomized, double-blind, placebo-controlled study aims to evaluate the effect of krill oil supplementation in patients with dry age-related macular degeneration (AMD). Participants will receive 4 capsules of krill oil or placebo daily for a period of 3 months. Outcomes will be evaluated after 3-month treatment to assess differences between the two study groups.
Where, as registered
No US site; China (1).
Not yet recruitingNCT06880939
Antarctic Krill Oil Functional Food Mitigates Bladder Cancer Treatment Side Effects
No phase
Qilu Hospital of Shandong University
About 210 people
Starts Jul 15, 2025 (estimated)
In plain words A study of krill oil in people 18 to 75, run by Qilu Hospital of Shandong University. It plans to enroll about 210 people at 1 site, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 18 to 75. Conditions: Urinary Bladder Neoplasms.
1\. Diagnosed bladder cancer: The patient needs to be diagnosed with bladder cancer through pathological examination and have undergone bladder cancer surgery.
2\. Planned to receive bladder infusion therapy: Patients need to plan to receive bladder infusion therapy after surgery and agree to participate in the study.
3\. Age range: 18 to 75 years old.
4\. Normal blood, liver and kidney function: Laboratory tests showed that the patient's blood routine, liver function and kidney function were within the normal range.
1 more inclusion criterion and the exclusion criteria are on the listing.
What it tests, as registered
Krill Oil Functional Food; Olive Oil
Registered summary
This randomized, double-blind, placebo-controlled, multicenter trial evaluates the efficacy and safety of Antarctic krill oil in reducing side effects of intravesical therapy for non-muscle-invasive bladder cancer (NMIBC). A total of 210 participants (18-75 years) will be randomized to receive either 2g/day of krill oil capsules (containing phospholipids, DHA, EPA, and astaxanthin) or placebo during intravesical treatment (epirubicin, pirarubicin, or BCG). Primary outcomes include bladder irritation symptoms (IPSS score), systemic adverse events, hematuria, and urinary tract infections. The full summary is on the listing.
Where, as registered
No US site; China (1).
Not yet recruitingNCT06880926
Antarctic Krill Oil for Knee Osteoarthritis Pain
Phase 2
Qilu Hospital of Shandong University
About 116 people
Starts Apr 1, 2025 (estimated)
In plain words A Phase 2 study of krill oil in people 45 to 75, run by Qilu Hospital of Shandong University. It plans to enroll about 116 people and lists no sites yet.
Who it lists and where
Who the trial lists, as registered
Lists people 45 to 75. Conditions: Osteoarthritis (OA) of the Knee; Osteoarthritis Knee Pain.
Aged 45-75 years；
Clinically diagnosed with knee osteoarthritis per the Chinese Guidelines for the Diagnosis and Treatment of Osteoarthritis (2018 edition) issued by the Chinese Medical Association, with Kellgren-Lawrence grade 1-3；
Knee pain Visual Analog Scale (VAS) score between 4.0 and 8.0；
Ability to comprehend and complete VAS and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) assessments；
1 more inclusion criterion and the exclusion criteria are on the listing.
What it tests, as registered
Krill oil; Olive Oil
Registered summary
The goal of this clinical trial is to evaluate the effectiveness and safety of Antarctic Krill Oil (AKO) as a dietary supplement in managing pain associated with knee osteoarthritis (OA). The main questions it aims to answer are: ①Does AKO reduce daily pain intensity in participants with moderate knee OA? ②What adverse effects do participants experience when taking AKO? Researchers will conduct a randomized, double-blind study comparing AKO to a placebo (identical appearance without active components) to assess: * Changes in joint pain severity; ②Functional improvement in daily activities;… The full summary is on the listing.
Where, as registered
No sites listed yet.
Not yet recruitingNCT07394517
ATLANTIS Trial: Phospholipid Omega-3 Versus Conventional Omega-3
No phase
Fundación del Caribe para la Investigación Biomédica
About 105 people
Starts Mar 2026 (estimated)
In plain words A study of krill oil in people 18 and older, run by Fundación del Caribe para la Investigación Biomédica. It plans to enroll about 105 people at 1 site, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 18 and older. Conditions: Mixed Dyslipidemia.
Adults aged 18 years or older.
Diagnosis of mixed dyslipidemia.
Fasting triglyceride levels between 135 and 499 mg/dL.
Body mass index (BMI) ≥27 kg/m².
3 more inclusion criteria and the exclusion criteria are on the listing.
This study is a clinical trial designed to compare two forms of omega-3 supplements in adults with mixed dyslipidemia. Mixed dyslipidemia is a condition in which blood fat levels, such as triglycerides and cholesterol, are not within the recommended range and may increase the risk of cardiovascular disease. Participants in this study will be randomly assigned to receive one of three study products: a phospholipid-based omega-3 supplement (Ruby-O) at a moderate dose, the same phospholipid-based omega-3 supplement at a higher dose, or a conventional omega-3 supplement in triglyceride form. The full summary is on the listing.